News
Parkinson’s disease (PD) is a neurodegenerative disease of the central nervous system characterized by the loss of dopaminergic neurons in the substantia nigra and the abnormal aggregation of ...
Mark Bodmer and Jonathan Lewis of UCB pharma talk us though the partnering model at UCB, and how partnering can drive innovation. The world is changing and it’s no different for the ...
If the FDA approves nipocalimab, the long-term data could form part of J&J’s pitch for the gMG market. The labels for ...
UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide. The company's primary products include Cimzia for inflammatory TNF ...
Pharmaceutical companies are spending large sums of money on R&D in an effort to develop a new treatment that will either improve disease management or slow its progression. New technologies like ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results